The biopharmaceutical giant AbbVie Inc. finds itself embroiled in a cybersecurity incident after the notorious Cl0p hacking group boasted about breaching the company’s data on their website. This revelation prompts the FBI to launch an investigation into the exploitation of a vulnerability within the MOVEit software by malicious ransomware actors, indicating the seriousness of the breach.
AbbVie is diligently conducting its own investigation to determine the scope of the intrusion and assess the extent of the compromised data. While the company has confirmed that the breached data was utilized in a “limited deployment” across their network, they have promptly notified law enforcement to address the matter effectively.
The incident underscores the persistent threat posed by cybercriminals to organizations across industries, highlighting the need for robust cybersecurity measures and swift response protocols. As investigations unfold, stakeholders await further details on the nature of the breach and any potential impacts on AbbVie’s operations and stakeholders.
